Nicolás Galmarini, MBA is a biotech entrepreneur focused on translating scientific innovation into scalable business opportunities. As Co-founder and CEO of NanoVet Biotech, he leads the development of next-generation veterinary biologics based on a camelid-derived nanobody platform, engineered for systemic administration with extended half-life in chronic and immune-mediated diseases.

With over 15 years of experience across the pharmaceutical value chain, Nicolás has built a strong track record in business development and the advancement of complex biological solutions. His experience spans both scientific and commercial domains, enabling him to effectively bridge technical development and execution.

He brings a multidisciplinary perspective that integrates science, business, and strategy, with a strong emphasis on partnerships as a key driver to accelerate innovation and bring new therapies to market.